Gilead Sciences Inc. (NASDAQ: GILD) announced it will acquire Tubulis GmbH, a Germany-based clinical-stage biotechnology company developing antibody-drug conjugates for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE